Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies-Reference-Cited by-同舟云学术

Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies

Published:2021-05 Issue:5 Volume:2 Page:100275
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Dufloo Jérémy,Grzelak Ludivine,Staropoli Isabelle,Madec Yoann,Tondeur Laura,Anna François,Pelleau Stéphane,Wiedemann Aurélie,Planchais Cyril,Buchrieser Julian,Robinot Rémy,Ungeheuer Marie-Noelle,Mouquet Hugo,Charneau Pierre,White Michael,Lévy Yves,Hoen Bruno,Fontanet Arnaud,Schwartz Olivier,Bruel Timothée

Funder

Agence nationale de la recherche

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference63 articles.

1. A new coronavirus associated with human respiratory disease in China;Wu;Nature,2020

2. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

3. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2;Gorbalenya;Nat. Microbiol.,2020

4. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe;Flaxman;Nature,2020

5. Clinical characteristics of coronavirus disease 2019 in China;Guan;N. Engl. J. Med.,2020

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering Fc-effector functions against SARS-CoV-2;Trends in Microbiology;2024-08

2. A spike virosome vaccine induces pan-sarbecovirus antibody responses in mice;iScience;2024-05

3. The Papain-like Protease Domain of Severe Acute Respiratory Syndrome Coronavirus 2 Conjugated with Human Beta-Defensin 2 and Co1 Induces Mucosal and Systemic Immune Responses against the Virus;Vaccines;2024-04-19

4. Hybrid humoral immune response of Pacific Islanders to BNT162b2 vaccination and Delta/Omicron infection: a cohort study;2024-04-10

5. Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies;iScience;2024-04